Purchases and Sales Made in Q3 2024 in Immunovant, Inc. (IMVT)
This table provides information about the institutional ownership of Immunovant, Inc. (IMVT) during Q3 2024. The information is specifically focused on institutions that hold shares of Immunovant, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2024
Q3 2024
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-153K- 11.21% |
$4.2M - $4.2M
|
1.21M
$33.3M
|
|
|
Nov 07, 2024
Q3 2024
|
Skandinaviska Enskilda Banken Ab (Publ)
Stockholm, V7 |
SELL
|
- |
-189K- 68.06% |
$5.19M - $5.19M
|
88.5K
$2.43M
|
|
|
Nov 14, 2024
Q3 2024
|
Canada Pension Plan Investment Board
Toronto Ontario, A6 |
SELL
|
- |
-199K- 99.4% |
$5.46M - $5.46M
|
1.2K
$33K
|
|
|
Nov 13, 2024
Q3 2024
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-199K- 51.3% |
$5.48M - $5.48M
|
189K
$5.2M
|
|
|
Nov 14, 2024
Q3 2024
|
Soleus Capital Management, L.P.
Greenwich, CT |
SELL
|
- |
-242K- 96.16% |
$6.66M - $6.66M
|
9.68K
$266K
|
|
|
Nov 13, 2024
Q3 2024
|
Stem Point Capital LP
New York, NY |
SELL
|
- |
-341K- 33.69% |
$9.38M - $9.38M
|
671K
$18.5M
|
|
|
Nov 14, 2024
Q3 2024
|
Pfm Health Sciences, LP
San Francisco, CA |
SELL
|
- |
-350K- 74.03% |
$9.62M - $9.62M
|
123K
$3.38M
|
|
|
Nov 14, 2024
Q3 2024
|
Woodline Partners LP
San Francisco, CA |
SELL
|
- |
-408K- 22.4% |
$11.2M - $11.2M
|
1.41M
$38.9M
|
|
|
Nov 14, 2024
Q3 2024
|
Avidity Partners Management LP
Dallas, TX |
SELL
|
- |
-809K- 89.1% |
$22.3M - $22.3M
|
99K
$2.72M
|